Kevin Anderson is a Clinical Operations Director. He has worked in drug development throughout his career at a number of leading companies including Amgen, Biogen, Shire and for the last six years Alexion. He is currently overseeing a portfolio of rare disease neurology programs and a multinational team of Clinical Project Leaders. He received his MBA from Boston College and his BA in from Eastern University.
